ALLMedicine™ Intrauterine Device Center

Aug 6th, 2022 - Long-acting and reversible contraceptives (LARC) are the most widely used form of female contraception worldwide, however they have significant side-effects that often result in early removal. Most LARCs are hormonal, but the use of exogenous horm...

Aug 5th, 2022 - To evaluate associations between use of seven progestogens and incident acute venous thromboembolism (VTE) among women of reproductive age. This nested matched case-control study identified women aged 15-49 years from January 1, 2010, through Octo...

Aug 3rd, 2022 - More women in China have received intrauterine devices (IUDs) than in the rest of the world combined. Recent reports have recognized a growing problem of delayed removal of these IUDs after menopause, especially in rural China, but few studies hav...

Aug 1st, 2022 - Purpose: The purpose of this study is to evaluate FFNP PET/MRI's utility for predicting response to Levonorgestrel-releasing Intrauterine Device (LR-IUD) hormonal therapy for Complex Atypical hyperplasia (CAH) and Endometrial Cancer (EC). Particip...

Jul 30th, 2022 - Assessing implementation fidelity is highly recommended, but successful approaches can be challenging. Family Planning Elevated (FPE) is a statewide contraceptive initiative which partnered with 28 health clinics across Utah. To assess implementat...

Dec 3rd, 2015 - To provide guidelines for health care providers on the use of contraceptive methods to prevent pregnancy and on the promotion of healthy sexuality. Guidance for Canadian practitioners on overall effectiveness, mechanism of action, indications, con...

Aug 1st, 2022 - Purpose: The purpose of this study is to evaluate FFNP PET/MRI's utility for predicting response to Levonorgestrel-releasing Intrauterine Device (LR-IUD) hormonal therapy for Complex Atypical hyperplasia (CAH) and Endometrial Cancer (EC). Particip...

Jul 29th, 2022 - This study aimed to apply to the Gynecology and Obstetrics Clinic of Istanbul Health Sciences University Kanuni Sultan Süleyman Training and Research Hospital between August 2020 and December 2021, diagnosed with abnormal uterine bleeding between ...

Jul 22nd, 2022 - Population increase in Egypt is a major problem with the fertility rate 3.5 children per woman the postpartum period starts after the birth of the placenta and lasts for 6-8weeks after delivery Women resume sexual activity 1 to 2 months after deli...

Jul 19th, 2022 - The aim of this study is to This study is designed to compare between lidocaine spray 10% and oral ibuprofen as an adequate method for decreasing pain during copper intrauterine contraceptive device insertion . Research question: Which of both dru...

Jul 15th, 2022 - This is a prospective, two-center, randomized controlled trial evaluating whether music reduces pain and improves satisfaction during IUD insertion. Computer-generated randomization assignments will allocate subjects to either music or standard pr...

Jun 23rd, 2022 - Women for whom an intrauterine device (IUD) is inserted from 4 days to 6 weeks after giving birth, as well as those who are breastfeeding, are at higher risk of the contraceptive device puncturing their uterus, new research shows. Dr Susan Reed Th...

May 5th, 2022 - New phase 3 data support the use of the levonorgestrel 52 mg intrauterine device (IUD) in nulliparous women with obesity and heavy menstrual bleeding. The findings, presented at the 2022 annual meeting of the American College of Obstetricians and ...

Feb 14th, 2022 - To the Editor: Sarcoidosis is a multisystem, noncaseating, granulomatous disorder thought to occur from a combination of immunologic, genetic, and environmental factors. 1 Often referred to as the “great imitator,” the cutaneous manifestations of s.

Oct 19th, 2021 - The progesterone only pill is generally safe to be prescribed remotely, because recent blood pressure and weight are not required according to a session on remote prescribing in women’s health at the Royal College of General Practitioners (RCGP) a...

Sep 18th, 2021 - Key clinical point: The overall rate of uterine perforation after intrauterine device (IUD) insertion was less than 1%, but higher with placement at 4-8 weeks postpartum compared to 9-36 weeks postpartum. Major finding: After adjusting for multipl.